drugset / Trial / NCT05696067
Evaluation of Corfluvec Vaccine for the Prevention of COVID-19 in Healthy Volunteers
Phase 1/2
Completed
200 enrolled
Tatyana Zubkova
MDP-CRO, LLC · collabSt. Petersburg State Pavlov Medical University · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The aim of the study is to investigate the safety and immunogenicity of a two-component intranasal vaccine for the prevention of COVID-19 in healthy volunteers 18-60 years old
Timeline
- Start
- 2022-09-13
- Primary completion
- 2022-12-30
- Completion
- 2023-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Corfluvec component 1 | Vaccine | 7.2 unknown | Intranasal |
| Subject | Corfluvec component 1 | Vaccine | 8 unknown | Intranasal |
| Subject | Corfluvec component 2 | Vaccine | 7.5 unknown | Intranasal |
| Subject | Corfluvec component 2 | Vaccine | 8.3 unknown | Intranasal |